QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Procter & Gamble Earnings: A Gamble Worth Taking

Procter & Gamble Earnings: A Gamble Worth Taking

Key Points

  • Procter & Gamble is set to release fiscal Q2 earnings this week on January 19th.
  • In fiscal Q1, more than half of the company’s top 50 categories held or gained market share.
  • Historically, its financials have been stronger in the first six months of the fiscal year.
  • Wall Street is forecasting 1% and 5% declines in fiscal Q2 revenue and earnings but analysts are anticipating Q3 and Q4 profits to be up 2% and 8% respectively.
  • 5 stocks we like better than Procter & Gamble

Even consumer staples juggernaut The Procter & Gamble Company NYSE: PG is susceptible to macroeconomic pressures.

In October 2022, the maker of Tide, Bounty, Oral B and many other household essentials missed quarterly earnings expectations. It ended a multiyear streak of Street topping profits — and pushed the stock below $130 and approximately $40 off its January 2022 record peak.

Since then, Procter & Gamble shares have rallied back above $150 thanks to a broad market uptrend and support from sell-side research groups. Last week, Raymond James praised P&G’s strategic pivot towards faster-growing products and gave the stock a $170 target.

Still, heading into Thursday morning’s fiscal Q2 earnings release, the company finds itself in unfamiliar territory following last quarter’s shortfall. With the bar set relatively low this time, a P&G earnings play could ‘clean up.’

How Did Procter & Gamble Perform in Fiscal 2022?

P&G’s fiscal 2022 concluded with the quarter that ended June 30, 2022, which was influenced by a combination of pandemic and inflationary factors. In the first half of the year, when stockpiling cleaning supplies was still a thing, sales reached record levels and profits matched early Covid levels. A more cautious consumer and higher expenses produced weaker results in the back half. 

There is also an element of seasonality to consider with P&G. Historically, its financials have been stronger in the first six months of the fiscal year when summer barbecues and holiday spending are in full force. This is what makes this week’s report so important.

In fiscal Q1, organic revenue was up 7% year-over-year, but with volumes declining 3%, this was about price increases. It confirmed that P&G’s strong brand portfolio gives it pricing power but suggested shoppers are spending less and shifting to the cheaper private label stuff.

Factoring in negative foreign exchange effects reported sales were up just 1%. Add in higher commodity, transportation and packaging costs, and profits were down 2.5%.


Ahead of the Q1 earnings release, private investment group TRC Capital presented an unsolicited “mini-tender offer” to buy as many as one million P&G shares at a price of $118.63. This represented a 4.5% discount to where the stock was trading. Naturally, P&G recommended that shareholders reject the offer because of the inferior price and conditions associated with the tender. 

While this was a temporary distraction for the company, it signaled to the market that TRC considered the shares undervalued. Interestingly, this helped establish a bottom for P&G, which has rallied more than 20%.

What Are Procter & Gamble’s Fiscal Q2 Earnings Expectations?

The themes of last quarter’s report — lower volumes, cost inflation and currency headwinds — will likely reappear in P&G’s January 19th update. Wall Street forecasts 1% and 5% declines in fiscal Q2 revenue and earnings, respectively. 

The good news is 1) these are hurdles that P&G’s pricing power and efficiency initiatives can overcome and 2) as raw materials and distribution expenses moderate, bottom-line results are expected to improve in the second half of the year. 

Analysts anticipate Q3 and Q4 profits to be up 2% and 8%, respectively. If earnings growth accelerates as expected, renewed faith in P&G shares and a run to fresh all-time highs could soon follow.

For fiscal 2023, management sees sales decreased by 1% to 3% and earnings per share (EPS) flat at 4%. For these estimates to be surpassed, the company will likely have to lean on categories performing best in this environment — home care, health care and beauty.

Is Procter & Gamble Stock a Good Investment?

Lost in P&G’s recent headline numbers is that market share is holding up well despite the threat of inexpensive generics. In fiscal Q1, more than half of the company’s top 50 categories held or gained market share. This speaks to the quality and brand recognition of P&G’s portfolio — and suggests families aren’t likely to deviate much from the products they’ve known and trusted for decades (if not generations). This is what makes P&G one of the most reliable equities available.

If last week’s assertion by ‘big banks’ is true, 2023 will bring a mild recession. Consumers may spend less on discretionary items to weather the storm and stick to the basics. Therefore, defensive names like P&G could continue to hold up relatively well while tech and other growth names remain out of favor.

Regardless of how the fiscal Q2 report moves the stock, P&G is never a bad idea as a long-term value holding. The unparalleled 67-year dividend hike streak alone puts it 'head & shoulders' above its blue-chip peers.

→ Laser breakthrough could send stock soaring 2,467% (From Behind the Markets) (Ad)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Procter & Gamble (PG)
4.4869 of 5 stars
$160.56+0.1%2.34%26.89Moderate Buy$167.50
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: